Status:
RECRUITING
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
AstraZeneca
Niox Group Plc
Conditions:
Asthma
Inflammation
Eligibility:
All Genders
6+ years
Brief Summary
The objective of this observational study is to assess the relevance of inflammometry (based on the measurement of fractional exhaled nitric oxide (FeNO) and blood eosinophil count (BEC)) as a tool fo...
Detailed Description
BACKROUND : Asthma is one of the most prevalent chronic diseases worldwide. In Canada, it affects 11% of the population. In Quebec, an estimated 900,000 people suffer from asthma, including 300,000 ch...
Eligibility Criteria
Inclusion
- patients age 6 and older
- referred by primary care ofr an asthma diagnostic test (spirometry or methacholine challenge)
Exclusion
- referred by pulmonologist
Key Trial Info
Start Date :
March 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06981169
Start Date
March 24 2025
End Date
July 1 2027
Last Update
May 20 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Sainte-Justine
Montreal, Quebec, Canada, H3T 1C5
2
Montreal Children's Hospital
Montreal, Quebec, Canada, H4A 3H9
3
CIUSSS de l'Estrie - CHUS
Sherbrooke, Quebec, Canada, J1H 5N4